D-1287-2022 Class II Terminated
FDA drug recall D-1287-2022 was initiated by Dr. Reddy's Laboratories, Inc. on Jul 13, 2022 and is designated Class II. Reason for recall: FAILED DISSOLUTION SPECIFICATIONS The recall status is terminated (terminated Dec 6, 2023). Affected quantity: 2,892 cartons.
Recall Details
- Product Type
- Drugs
- Report Date
- Aug 3, 2022
- Initiation Date
- Jul 13, 2022
- Termination Date
- Dec 6, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,892 cartons
Product Description
Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100-count blisters per carton, 10 Packs of 10 Tablets Each, Rx Only, Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540, Made in India, blister barcode 4359856079, NDC 43598-560-78
Reason for Recall
FAILED DISSOLUTION SPECIFICATIONS
Distribution Pattern
Nationwide in the USA
Code Information
Lot T2100514, Exp 01/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1287-2022
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 25, 2026